Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice

Breast cancer represents the second most common cancer type worldwide and has remained the leading cause of cancer-related deaths among women. The differentiation antigen NY-BR-1 appears overexpressed in invasive mammary carcinomas compared to healthy breast tissue, thus representing a promising tar...

Full description

Saved in:
Bibliographic Details
Main Authors: Gardyan, Adriane (Author) , Zörnig, Inka (Author) , Aulmann, Sebastian (Author) , Ruggiero, Eliana (Author) , Schmidt, Manfred (Author) , Halama, Niels (Author) , Kalle, Christof von (Author) , Schneeweiss, Andreas (Author) , Jäger, Dirk (Author) , Eichmüller, Stefan B. (Author)
Format: Article (Journal)
Language:English
Published: 12 Nov 2014
In: International journal of Cancer Studies & Research
Year: 2015, Volume: 136, Issue: 11, Pages: 2588-2597
ISSN:2167-9118
DOI:10.1002/ijc.29322
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1002/ijc.29322
Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/10.1002/ijc.29322/abstract
Get full text
Author Notes:Adriane Gardyan, Wolfram Osen, Inka Zörnig, Lilli Podola, Maria Agarwal, Sebastian Aulmann, Eliana Ruggiero, Manfred Schmidt, Niels Halama, Barbara Leuchs, Christof von Kalle, Philipp Beckhove, Andreas Schneeweiss, Dirk Jäger and Stefan B. Eichmüller

MARC

LEADER 00000caa a2200000 c 4500
001 1561056537
003 DE-627
005 20220813201041.0
007 cr uuu---uuuuu
008 170720s2015 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.29322  |2 doi 
035 |a (DE-627)1561056537 
035 |a (DE-576)491056532 
035 |a (DE-599)BSZ491056532 
035 |a (OCoLC)1340977671 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gardyan, Adriane  |e VerfasserIn  |0 (DE-588)1050052986  |0 (DE-627)783252331  |0 (DE-576)322464595  |4 aut 
245 1 0 |a Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice  |c Adriane Gardyan, Wolfram Osen, Inka Zörnig, Lilli Podola, Maria Agarwal, Sebastian Aulmann, Eliana Ruggiero, Manfred Schmidt, Niels Halama, Barbara Leuchs, Christof von Kalle, Philipp Beckhove, Andreas Schneeweiss, Dirk Jäger and Stefan B. Eichmüller 
264 1 |c 12 Nov 2014 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.07.2017 
520 |a Breast cancer represents the second most common cancer type worldwide and has remained the leading cause of cancer-related deaths among women. The differentiation antigen NY-BR-1 appears overexpressed in invasive mammary carcinomas compared to healthy breast tissue, thus representing a promising target antigen for T cell based tumor immunotherapy approaches. Since efficient immune attack of tumors depends on the activity of tumor antigen-specific CD4+ effector T cells, NY-BR-1 was screened for the presence of HLA-restricted CD4+ T cell epitopes that could be included in immunological treatment approaches. Upon NY-BR-1-specific DNA immunization of HLA-transgenic mice and functional ex vivo analysis, a panel of NY-BR-1-derived library peptides was determined that specifically stimulated IFNγ secretion among splenocytes of immunized mice. Following in silico analyses, four candidate epitopes were determined which were successfully used for peptide immunization to establish NY-BR-1-specific, HLA-DRB1*0301- or HLA-DRB1*0401-restricted CD4+ T cell lines from splenocytes of peptide immunized HLA-transgenic mice. Notably, all four CD4+ T cell lines recognized human HLA-DR-matched dendritic cells (DC) pulsed with lysates of NY-BR-1 expressing human tumor cells, demonstrating natural processing of these epitopes also within the human system. Finally, CD4+ T cells specific for all four CD4+ T cell epitopes were detectable among PBMC of breast cancer patients, showing that CD4+ T cell responses against the new epitopes are not deleted nor inactivated by self-tolerance mechanisms. Our results present the first NY-BR-1-specific HLA-DRB1*0301- and HLA-DRB1*0401-restricted T cell epitopes that could be exploited for therapeutic intervention against breast cancer. 
650 4 |a breast cancer 
650 4 |a CD4+ T cells 
650 4 |a HLA-transgenic mice 
650 4 |a immunotherapy 
650 4 |a T cell epitope 
650 4 |a tumor antigen 
700 1 |a Zörnig, Inka  |e VerfasserIn  |0 (DE-588)1022346741  |0 (DE-627)716954850  |0 (DE-576)36517937X  |4 aut 
700 1 |a Aulmann, Sebastian  |d 1973-  |e VerfasserIn  |0 (DE-588)124520197  |0 (DE-627)363393021  |0 (DE-576)294211519  |4 aut 
700 1 |a Ruggiero, Eliana  |e VerfasserIn  |0 (DE-588)1033883174  |0 (DE-627)742729400  |0 (DE-576)38155547X  |4 aut 
700 1 |a Schmidt, Manfred  |d 1967-2022  |e VerfasserIn  |0 (DE-588)122922301  |0 (DE-627)706092430  |0 (DE-576)293477620  |4 aut 
700 1 |a Halama, Niels  |d 1977-  |e VerfasserIn  |0 (DE-588)13087325X  |0 (DE-627)507228723  |0 (DE-576)251045706  |4 aut 
700 1 |a Kalle, Christof von  |d 1962-  |e VerfasserIn  |0 (DE-588)1036481115  |0 (DE-627)75107926X  |0 (DE-576)168957396  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Eichmüller, Stefan B.  |d 1960-  |e VerfasserIn  |0 (DE-588)1025289226  |0 (DE-627)721986951  |0 (DE-576)37016704X  |4 aut 
773 0 8 |i Enthalten in  |t International journal of Cancer Studies & Research  |d Lewes, Del. : SciDoc Publ., 2012  |g 136(2015), 11, Seite 2588-2597  |h Online-Ressource  |w (DE-627)793951364  |w (DE-600)2781466-X  |w (DE-576)412046806  |x 2167-9118  |7 nnas  |a Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice 
773 1 8 |g volume:136  |g year:2015  |g number:11  |g pages:2588-2597  |g extent:10  |a Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice 
856 4 0 |u http://dx.doi.org/10.1002/ijc.29322  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://onlinelibrary.wiley.com/doi/10.1002/ijc.29322/abstract  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170720 
993 |a Article 
994 |a 2015 
998 |g 1025289226  |a Eichmüller, Stefan B.  |m 1025289226:Eichmüller, Stefan B.  |d 140000  |d 60000  |e 140000PE1025289226  |e 60000PE1025289226  |k 0/140000/  |k 0/60000/  |p 15  |y j 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 14 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 13 
998 |g 1036481115  |a Kalle, Christof von  |m 1036481115:Kalle, Christof von  |d 910000  |e 910000PK1036481115  |k 0/910000/  |p 11 
998 |g 13087325X  |a Halama, Niels  |m 13087325X:Halama, Niels  |d 910000  |d 910100  |e 910000PH13087325X  |e 910100PH13087325X  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 122922301  |a Schmidt, Manfred  |m 122922301:Schmidt, Manfred  |d 140000  |e 140000PS122922301  |k 0/140000/  |p 8 
998 |g 1033883174  |a Ruggiero, Eliana  |m 1033883174:Ruggiero, Eliana  |d 910000  |e 910000PR1033883174  |k 0/910000/  |p 7 
998 |g 124520197  |a Aulmann, Sebastian  |m 124520197:Aulmann, Sebastian  |d 50000  |e 50000PA124520197  |k 0/50000/  |p 6 
998 |g 1022346741  |a Zörnig, Inka  |m 1022346741:Zörnig, Inka  |d 910000  |d 910100  |e 910000PZ1022346741  |e 910100PZ1022346741  |k 0/910000/  |k 1/910000/910100/  |p 3 
999 |a KXP-PPN1561056537  |e 2974599206 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1561056537"],"doi":["10.1002/ijc.29322"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"note":["Gesehen am 20.07.2017"],"relHost":[{"pubHistory":["1.2012 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"IJCR"},{"title":"International journal of Cancer Studies and Research"}],"language":["eng"],"recId":"793951364","disp":"Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic miceInternational journal of Cancer Studies & Research","note":["Gesehen am 14.08.20"],"id":{"eki":["793951364"],"issn":["2167-9118"],"zdb":["2781466-X"]},"part":{"issue":"11","extent":"10","pages":"2588-2597","year":"2015","volume":"136","text":"136(2015), 11, Seite 2588-2597"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"International journal of Cancer Studies & Research","subtitle":"IJCR","title":"International journal of Cancer Studies & Research"}],"origin":[{"dateIssuedKey":"2012","publisherPlace":"Lewes, Del.","publisher":"SciDoc Publ.","dateIssuedDisp":"2012-"}]}],"name":{"displayForm":["Adriane Gardyan, Wolfram Osen, Inka Zörnig, Lilli Podola, Maria Agarwal, Sebastian Aulmann, Eliana Ruggiero, Manfred Schmidt, Niels Halama, Barbara Leuchs, Christof von Kalle, Philipp Beckhove, Andreas Schneeweiss, Dirk Jäger and Stefan B. Eichmüller"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"12 Nov 2014"}],"recId":"1561056537","person":[{"role":"aut","given":"Adriane","display":"Gardyan, Adriane","family":"Gardyan"},{"role":"aut","family":"Zörnig","display":"Zörnig, Inka","given":"Inka"},{"role":"aut","display":"Aulmann, Sebastian","given":"Sebastian","family":"Aulmann"},{"given":"Eliana","display":"Ruggiero, Eliana","family":"Ruggiero","role":"aut"},{"family":"Schmidt","given":"Manfred","display":"Schmidt, Manfred","role":"aut"},{"display":"Halama, Niels","given":"Niels","family":"Halama","role":"aut"},{"family":"Kalle","given":"Christof von","display":"Kalle, Christof von","role":"aut"},{"display":"Schneeweiss, Andreas","given":"Andreas","family":"Schneeweiss","role":"aut"},{"family":"Jäger","display":"Jäger, Dirk","given":"Dirk","role":"aut"},{"role":"aut","display":"Eichmüller, Stefan B.","given":"Stefan B.","family":"Eichmüller"}],"title":[{"title":"Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice","title_sort":"Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice"}],"language":["eng"]} 
SRT |a GARDYANADRIDENTIFICA1220